Bristol, Tempus AI partnering with Pathos AI to advance neurological treatments

Bristol Myers Squibb and Tempus AI partner with Pathos AI to advance Alzheimer’s research with AI-driven datasets and smarter trials. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real